RESHAW clinical study, with Veri-te™
The RESHAW (Resveratrol Supporting Healthy Aging in Women) clinical study followed 125 postmenopausal women during a 24-month crossover comparison. Volunteers were randomized to take two capsules containing 75mg of Veri-te™ resveratrol daily or a matching placebo supplement for 12 months, followed by the alternate treatment for a further 12 months.
Significant benefits were seen for cognitive & cerebrovascular function, longevity, mood & overall well-being, menopausal discomfort and bone health.
Long-term effects of resveratrol on cognition, cerebrovascular function and cardio-metabolic markers in postmenopausal women
Regular supplementation with resveratrol improves bone mineral density in postmenopausal women
Sustained cerebrovascular and cognitive benefits of resveratrol in postmenopausal women
Long-term resveratrol supplementation improves pain perception, menopausal symptoms, and overall well-being in postmenopausal women